{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:43:27Z","timestamp":1790757807340,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T00:00:00Z","timestamp":1508025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00253-017-8557-1","type":"journal-article","created":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T06:37:30Z","timestamp":1508049450000},"page":"8165-8179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-9546","authenticated-orcid":false,"given":"B. Vijayalakshmi","family":"Ayyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Zouhair","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,15]]},"reference":[{"key":"8557_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","volume":"52","author":"N Avidan","year":"2014","unstructured":"Avidan N, Le Panse R, Berrih-Aknin S, Miller A (2014) Genetic basis of myasthenia gravis\u2014a comprehensive review. J Autoimmun 52:146\u2013153","journal-title":"J Autoimmun"},{"key":"8557_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ab.2010.07.033","volume":"407","author":"BV Ayyar","year":"2010","unstructured":"Ayyar BV, Hearty S, O\u2019Kennedy R (2010) Highly sensitive recombinant antibodies capable of reliably differentiating heart-type fatty acid binding protein from noncardiac isoforms. Anal Biochem 407:165\u2013171","journal-title":"Anal Biochem"},{"key":"8557_CR3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/IAI.00063-15","volume":"83","author":"BV Ayyar","year":"2015","unstructured":"Ayyar BV, Aoki KR, Atassi MZ (2015a) The C-terminal heavy-chain domain of botulinum neurotoxin A is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions. Infect Immun 83:1465\u20131476","journal-title":"Infect Immun"},{"key":"8557_CR4","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00253-014-6268-4","volume":"99","author":"BV Ayyar","year":"2015","unstructured":"Ayyar BV, Hearty S, O\u2019Kennedy R (2015b) Facile domain rearrangement abrogates expression recalcitrance in a rabbit scFv. Appl Microbiol Biotechnol 99:2693\u20132703","journal-title":"Appl Microbiol Biotechnol"},{"key":"8557_CR5","volume":"5","author":"BV Ayyar","year":"2015","unstructured":"Ayyar BV, Tajhya RB, Beeton C, Zouhair Atassi M (2015c) Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep 5:15776","journal-title":"Sci Rep"},{"key":"8557_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymeth.2017.01.009","volume":"116","author":"BV Ayyar","year":"2017","unstructured":"Ayyar BV, Arora S, Ravi SS (2017) Optimizing antibody expression: the nuts and bolts. Methods 116:51\u201362","journal-title":"Methods"},{"key":"8557_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","volume":"505","author":"S Berrih-Aknin","year":"1987","unstructured":"Berrih-Aknin S, Morel E, Raimond F, Safar D, Gaud C, Binet JP, Levasseur P, Bach JF (1987) The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann N Y Acad Sci 505:50\u201370","journal-title":"Ann N Y Acad Sci"},{"key":"8557_CR8","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet X, Lefranc M-P, Giudicelli V (2008) IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36:W503\u2013W508","journal-title":"Nucleic Acids Res"},{"key":"8557_CR9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/19420862.2015.1117720","volume":"8","author":"A Bujotzek","year":"2016","unstructured":"Bujotzek A, Lipsmeier F, Harris SF, Benz J, Kuglstatter A, Georges G (2016) VH-VL orientation prediction for antibody humanization candidate selection: a case study. MAbs 8:288\u2013305","journal-title":"MAbs"},{"key":"8557_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI83840","volume":"126","author":"N Chamberlain","year":"2016","unstructured":"Chamberlain N, Massad C, Oe T, Cantaert T, Herold KC, Meffre E (2016) Rituximab does not reset defective early B cell tolerance checkpoints. J Clin Invest 126:282\u2013287","journal-title":"J Clin Invest"},{"key":"8557_CR11","doi-asserted-by":"crossref","unstructured":"Conti-Fine BM, Diethelm-Okita B, Ostlie N, Wang W, Milani M (2009) Immunopathogenesis of myasthenia gravis. In: Kaminski H J (ed) Myasthenia gravis and related disorders. Humana Press, Totowa, pp 43\u201370","DOI":"10.1007\/978-1-59745-156-7_3"},{"key":"8557_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/08916930600738581","volume":"39","author":"PR Deitiker","year":"2006","unstructured":"Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ (2006) Subtle differences in HLA DQ haplotype-associated presentation of AChR \u03b1-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity 39:277\u2013288","journal-title":"Autoimmunity"},{"key":"8557_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","volume":"38","author":"PR Deitiker","year":"2011","unstructured":"Deitiker PR, Oshima M, Smith RG, Mosier D, Atassi MZ (2011) Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet 38:55\u201362","journal-title":"Int J Immunogenet"},{"key":"8557_CR14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"8557_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pep.2010.05.009","volume":"73","author":"L Evans","year":"2010","unstructured":"Evans L, Hughes M, Waters J, Cameron J, Dodsworth N, Tooth D, Greenfield A, Sleep D (2010) The production, characterisation and enhanced pharmacokinetics of scFv\u2013albumin fusions expressed in Saccharomyces cerevisiae. Protein Expr Purif 73:113\u2013124","journal-title":"Protein Expr Purif"},{"key":"8557_CR16","volume":"4","author":"MMA Fernando","year":"2008","unstructured":"Fernando MMA, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4:e1000024","journal-title":"PLoS Genet"},{"key":"8557_CR17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-2836(92)91010-M","volume":"224","author":"J Foote","year":"1992","unstructured":"Foote J, Winter G (1992) Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 224:487\u2013499","journal-title":"J Mol Biol"},{"key":"8557_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1167\/iovs.08-2370","volume":"50","author":"E Furrer","year":"2009","unstructured":"Furrer E, Berdugo M, Stella C, Behar-Cohen F, Gurny R, Feige U, Lichtlen P, Urech DM (2009) Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti\u2013TNF-\u03b1 single-chain antibody, upon topical administration to the rabbit eye. Invest Ophthalmol Vis Sci 50:771\u2013778","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8557_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/abb.2013.44A011","volume":"4","author":"D Gil","year":"2013","unstructured":"Gil D, Schrum AG (2013) Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments. Adv Biosci Biotechnol 4:73\u201384","journal-title":"Adv Biosci Biotechnol"},{"key":"8557_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","volume":"1132","author":"M Giraud","year":"2008","unstructured":"Giraud M, Vandiedonck C, Garchon H-J (2008) Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 1132:180\u2013192","journal-title":"Ann N Y Acad Sci"},{"key":"8557_CR21","first-page":"716","volume":"2011","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli V, Lefranc M-P (2011) IMGT\/JunctionAnalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (Ig) and T cell receptors (TR). Cold Spring Harb Protoc 2011:716\u2013725","journal-title":"Cold Spring Harb Protoc"},{"key":"8557_CR22","first-page":"695","volume":"2011","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli V, Brochet X, Lefranc M-P (2011) IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (Ig) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc 2011:695\u2013715","journal-title":"Cold Spring Harb Protoc"},{"key":"8557_CR23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pep.2005.05.016","volume":"45","author":"J-Q Guo","year":"2006","unstructured":"Guo J-Q, Li Q-M, Zhou J-Y, Zhang G-P, Yang Y-Y, Xing G-X, Zhao D, You S-Y, Zhang C-Y (2006) Efficient recovery of the functional IP10-scFv fusion protein from inclusion bodies with an on-column refolding system. Protein Expr Purif 45:168\u2013174","journal-title":"Protein Expr Purif"},{"key":"8557_CR24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.36.5.618","volume":"36","author":"R Hohlfeld","year":"1986","unstructured":"Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV (1986) Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology 36:618\u2013621","journal-title":"Neurology"},{"key":"8557_CR25","volume-title":"Sequence of proteins of immunological interest","author":"E Kabat","year":"1991","unstructured":"Kabat E, Wu TT, Perry HM, Gottesman KS, Foeller C (1991) Sequence of proteins of immunological interest. Publication No 91-3242. US Public Health Services, NIH, Bethesda"},{"key":"8557_CR26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.23383","volume":"58","author":"J Kay","year":"2008","unstructured":"Kay J, Matteson EL, Dasgupta B, Nash P, Durez P, Hall S, Hsia EC, Han J, Wagner C, Xu Z, Visvanathan S, Rahman MU (2008) Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 58:964\u2013975","journal-title":"Arthritis Rheum"},{"key":"8557_CR27","first-page":"1186","volume":"18","author":"Y-J Kim","year":"2008","unstructured":"Kim Y-J, Neelamegam R, Heo M-A, Edwardraja S, Paik H-J, Lee S-G (2008) Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains. J Microbiol Biotechnol 18:1186\u20131190","journal-title":"J Microbiol Biotechnol"},{"key":"8557_CR28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jmb.2014.11.017","volume":"427","author":"JT Koerber","year":"2015","unstructured":"Koerber JT, Hornsby MJ, Wells JA (2015) An improved single-chain Fab platform for efficient display and recombinant expression. J Mol Biol 427:576\u2013586","journal-title":"J Mol Biol"},{"issue":"24","key":"8557_CR29","doi-asserted-by":"crossref","first-page":"17408","DOI":"10.1074\/jbc.M112.435289","volume":"288","author":"OV Kovalenko","year":"2013","unstructured":"Kovalenko OV, Olland A, Pich\u00e9-Nicholas N, Godbole A, King D, Svenson K, Calabro V, M\u00fcller MR, Barelle CJ, Somers W, Gill DS, Mosyak L, Tchistiakova L (2013) Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis. J Biol Chem 288(24):17408\u201317419","journal-title":"J Biol Chem"},{"key":"8557_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","volume":"43","author":"R Panse Le","year":"2010","unstructured":"Le Panse R, Bismuth J, Cizeron-Clairac G, Weiss JM, Cufi P, Dartevelle P, De Rosbo NK, Berrih-Aknin S (2010) Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 43:401\u2013412","journal-title":"Autoimmunity"},{"key":"8557_CR31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","volume":"171","author":"MI Leite","year":"2007","unstructured":"Leite MI, Jones M, Str\u00f6bel P, Marx A, Gold R, Niks E, Verschuuren JJGM, Berrih-Aknin S, Scaravilli F, Canelhas A, Morgan BP, Vincent A, Willcox N (2007) Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol 171:893\u2013905","journal-title":"Am J Pathol"},{"key":"8557_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbrc.2004.04.060","volume":"318","author":"D Lu","year":"2004","unstructured":"Lu D, Jimenez X, Witte L, Zhu Z (2004) The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody. Biochem Biophys Res Commun 318:507\u2013513","journal-title":"Biochem Biophys Res Commun"},{"key":"8557_CR33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/eji.1830230816","volume":"23","author":"A Mamalaki","year":"1993","unstructured":"Mamalaki A, Trakas N, Tzartos SJ (1993) Bacterial expression of a single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies. Eur J Immunol 23:1839\u20131845","journal-title":"Eur J Immunol"},{"key":"8557_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036603","volume":"7","author":"AH Maniaol","year":"2012","unstructured":"Maniaol AH, Elsais A, Lorentzen \u00c5R, Owe JF, Viken MK, S\u00e6ther H, Fl\u00e5m ST, Br\u00e5then G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CME, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. PLoS One 7:e36603","journal-title":"PLoS One"},{"key":"8557_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2013.12.007","volume":"52","author":"M Marino","year":"2014","unstructured":"Marino M, Maiuri MT, Di Sante G, Scuderi F, La Carpia F, Trakas N, Provenzano C, Zisimopoulou P, Ria F, Tzartos SJ, Evoli A, Bartoccioni E (2014) T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients. J Autoimmun 52:113\u2013121","journal-title":"J Autoimmun"},{"key":"8557_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.18.1.1","volume":"18","author":"HO McDevitt","year":"2000","unstructured":"McDevitt HO (2000) Discovering the role of the major histocompatibility complex in the immune response. Annu Rev Immunol 18:1\u201317","journal-title":"Annu Rev Immunol"},{"key":"8557_CR37","doi-asserted-by":"crossref","first-page":"i379","DOI":"10.1093\/bioinformatics\/bth945","volume":"20","author":"MY Monod","year":"2004","unstructured":"Monod MY, Giudicelli V, Chaume D, Lefranc M-P (2004) IMGT\/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V\u2013J and V\u2013D\u2013J JUNCTIONs. Bioinformatics 20:i379\u2013i385","journal-title":"Bioinformatics"},{"key":"8557_CR38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01025247","volume":"7","author":"B Mulac-Jericevic","year":"1988","unstructured":"Mulac-Jericevic B, Manshouri T, Yokoi T, Atassi MZ (1988) The regions of \u03b1-neurotoxin binding on the extracellular part of the \u03b1-subunit of human acetylcholine receptor. J Protein Chem 7:173\u2013177","journal-title":"J Protein Chem"},{"key":"8557_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(00)00199-5","volume":"105","author":"N Nakayashiki","year":"2000","unstructured":"Nakayashiki N, Oshima M, Deitiker PR, Ashizawa T, Atassi MZ (2000) Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol 105:131\u2013144","journal-title":"J Neuroimmunol"},{"key":"8557_CR40","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","volume":"146","author":"P Nancy","year":"2005","unstructured":"Nancy P, Berrih-Aknin S (2005) Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 146:2345\u20132353","journal-title":"Endocrinology"},{"key":"8557_CR41","first-page":"231","volume":"124","author":"W Ofosu-Appiah","year":"1994","unstructured":"Ofosu-Appiah W, Mokhtarian F, Shirazian D, Grob D (1994) Production of anti-acetylcholine receptor-a antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. J Lab Clin Med 124:231\u2013241","journal-title":"J Lab Clin Med"},{"key":"8557_CR42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/protein\/gzw001","volume":"29","author":"T Ojima-Kato","year":"2016","unstructured":"Ojima-Kato T, Fukui K, Yamamoto H, Hashimura D, Miyake S, Hirakawa Y, Yamasaki T, Kojima T, Nakano H (2016) \u2018Zipbody\u2019 leucine zipper-fused Fab in E. coli in vitro and in vivo expression systems. Protein Eng Des Sel 29:149\u2013157","journal-title":"Protein Eng Des Sel"},{"key":"8557_CR43","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.154.10.5245","volume":"154","author":"M Oshima","year":"1995","unstructured":"Oshima M, Atassi MZ (1995) Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. J Immunol 154:5245\u20135254","journal-title":"J Immunol"},{"issue":"2","key":"8557_CR44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08916939809008038","volume":"27","author":"M Oshima","year":"1998","unstructured":"Oshima M, Yokoi T, Deitiker P, Atassi MZ (1998) T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Autoimmunity 27(2):79\u201390","journal-title":"Autoimmunity"},{"key":"8557_CR45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2004.09.015","volume":"66","author":"M Oshima","year":"2005","unstructured":"Oshima M, Deitiker PR, Mosier DR, Smith RG, Atassi MZ (2005a) Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor \u03b1-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol 66:32\u201342","journal-title":"Hum Immunol"},{"key":"8557_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930500050491","volume":"38","author":"M Oshima","year":"2005","unstructured":"Oshima M, Ohtani M, Deitiker PR, Glenn Smith R, Mosier DR, Zouhair Atassi M (2005b) Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity 38:161\u2013169","journal-title":"Autoimmunity"},{"key":"8557_CR47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00249-5","volume":"94","author":"D Papanastasiou","year":"1999","unstructured":"Papanastasiou D, Mamalaki A, Eliopoulos E, Poulas K, Liolitsas C, Tzartos SJ (1999) Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor. J Neuroimmunol 94:182\u2013195","journal-title":"J Neuroimmunol"},{"key":"8557_CR48","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/eji.200526173","volume":"35","author":"E Protopapadakis","year":"2005","unstructured":"Protopapadakis E, Kokla A, Tzartos SJ, Mamalaki A (2005) Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci. Eur J Immunol 35:1960\u20131968","journal-title":"Eur J Immunol"},{"key":"8557_CR49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2016.4190","volume":"74","author":"KR Robeson","year":"2017","unstructured":"Robeson KR, Kumar A, Keung B, DiCapua DB, Grodinsky E, Patwa HS, Stathopoulos PA, Goldstein JM, O\u2019Connor KC, Nowak RJ (2017) Durability of the rituximab response in acetylcholine receptor autoantibody-positive myasthenia gravis. JAMA Neurol 74:60\u201366","journal-title":"JAMA Neurol"},{"key":"8557_CR50","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.4049\/jimmunol.157.7.3192","volume":"157","author":"JS Rosenberg","year":"1996","unstructured":"Rosenberg JS, Oshima M, Atassi MZ (1996) B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol 157:3192\u20133199","journal-title":"J Immunol"},{"key":"8557_CR51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","volume":"67","author":"G Saruhan-Direskeneli","year":"2006","unstructured":"Saruhan-Direskeneli G, Kili\u00e7 A, Parman Y, Serdaro\u011flu P, Deymeer F (2006) HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum Immunol 67:352\u2013358","journal-title":"Hum Immunol"},{"key":"8557_CR52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","volume":"166\u2013167","author":"G Saruhan-Direskeneli","year":"2016","unstructured":"Saruhan-Direskeneli G, Hughes T, Yilmaz V, Durmus H, Adler A, Alahgholi-Hajibehzad M, Aysal F, Yent\u00fcr SP, Akalin MA, Dogan O, Marx A, G\u00fclsen-Parman Y, Oflazer P, Deymeer F, Sawalha AH (2016) Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clin Immunol 166\u2013167:81\u201388","journal-title":"Clin Immunol"},{"key":"8557_CR53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/clin.1993.1030","volume":"66","author":"M Shenoy","year":"1993","unstructured":"Shenoy M, Oshima M, Atassi MZ, Christadoss P (1993) Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin Immunol Immunopathol 66:230\u2013238","journal-title":"Clin Immunol Immunopathol"},{"key":"8557_CR54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1590\/1414-431X20143276","volume":"47","author":"H Sun","year":"2014","unstructured":"Sun H, Wu G, Chen Y, Tian Y, Yue Y, Zhang G (2014) Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1. Braz J Med Biol Res 47:540\u2013547","journal-title":"Braz J Med Biol Res"},{"key":"8557_CR55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1107\/S1744309111027746","volume":"67","author":"A Teplyakov","year":"2011","unstructured":"Teplyakov A, Obmolova G, Malia T, Gilliland G (2011) Antigen recognition by antibody C836 through adjustment of VL\/VH packing. Acta Crystallogr Sect F Struct Biol Cryst Commun 67:1165\u20131167","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"8557_CR56","first-page":"541760","volume":"2012","author":"M Testi","year":"2012","unstructured":"Testi M, Terracciano C, Guagnano A, Testa G, Marfia GA, Pompeo E, Andreani M, Massa R (2012) Association of HLA-DQB1\u221705:02 and DRB1\u221716 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis. Autoimmune Dis 2012:541760","journal-title":"Autoimmune Dis"},{"key":"8557_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000452954","volume":"26","author":"BI Tiftikcioglu","year":"2017","unstructured":"Tiftikcioglu BI, Uludag IF, Zorlu Y, Pirim \u0130, Sener U, Tokucoglu F, Korucuk M (2017) Human leucocyte antigen B50 is associated with conversion to generalized myasthenia gravis in patients with pure ocular onset. Med Princ Pract 26:71\u201377","journal-title":"Med Princ Pract"},{"key":"8557_CR58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","volume":"79","author":"SJ Tzartos","year":"1982","unstructured":"Tzartos SJ, Seybold ME, Lindstrom JM (1982) Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci U S A 79:188\u2013192","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8557_CR59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","volume":"15","author":"S Tzartos","year":"1987","unstructured":"Tzartos S, Hochschwender S, Vasquez P, Lindstrom J (1987) Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J Neuroimmunol 15:185\u2013194","journal-title":"J Neuroimmunol"},{"key":"8557_CR60","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4049\/jimmunol.1601415","volume":"198","author":"JA Vander Heiden","year":"2017","unstructured":"Vander Heiden JA, Stathopoulos P, Zhou JQ, Chen L, Gilbert TJ, Bolen CR, Barohn RJ, Dimachkie MM, Ciafaloni E, Broering TJ, Vigneault F, Nowak RJ, Kleinstein SH, O\u2019Connor KC (2017) Dysregulation of B cell repertoire formation in myasthenia gravis patients revealed through deep sequencing. J Immunol 198:1460\u20131473","journal-title":"J Immunol"},{"key":"8557_CR61","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","volume":"101","author":"C Vandiedonck","year":"2004","unstructured":"Vandiedonck C, Beaurain G, Giraud M, Hue-Beauvais C, Eymard B, Tranchant C, Gajdos P, Dausset J, Garchon H-J (2004) Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci U S A 101:15464\u201315469","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8557_CR62","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.40.11.1060","volume":"40","author":"N Vijayan","year":"1977","unstructured":"Vijayan N, Vijayan VK, Dreyfus PM (1977) Acetylcholinesterase activity and menstrual remissions in myasthenia gravis. J Neurol Neurosurg Psychiatry 40:1060\u20131065","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8557_CR63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","volume":"52","author":"K Vrolix","year":"2014","unstructured":"Vrolix K, Fraussen J, Losen M, Stevens J, Lazaridis K, Molenaar PC, Somers V, Bracho MA, Le Panse R, Stinissen P, Berrih-Aknin S, Maessen JG, Van Garsse L, Buurman WA, Tzartos SJ, De Baets MH, Martinez-Martinez P (2014) Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. J Autoimmun 52:101\u2013112","journal-title":"J Autoimmun"},{"key":"8557_CR64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(99)00184-2","volume":"233","author":"Z Wang","year":"2000","unstructured":"Wang Z, Raifu M, Howard M, Smith L, Hansen D, Goldsby R, Ratner D (2000) Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3\u2032 to 5\u2032 exonuclease activity. J Immunol Methods 233:167\u2013177","journal-title":"J Immunol Methods"},{"key":"8557_CR65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","volume":"1132","author":"N Willcox","year":"2008","unstructured":"Willcox N, Leite MI, Kadota Y, Jones M, Meager A, Subrahmanyam P, Dasgupta B, Morgan BP, Vincent A (2008) Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci 1132:163\u2013173","journal-title":"Ann N Y Acad Sci"},{"key":"8557_CR66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo H-C, Marx A, Str\u00f6bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki AI, Newsom-Davis J, Cutter GR (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511\u2013522","journal-title":"N Engl J Med"},{"issue":"5","key":"8557_CR67","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1006\/jmbi.2000.4265","volume":"305","author":"A W\u00f6rn","year":"2001","unstructured":"W\u00f6rn A, Pl\u00fcckthun A (2001) Stability engineering of antibody single-chain Fv fragments. J Mol Biol 305(5):989\u20131010","journal-title":"J Mol Biol"},{"key":"8557_CR68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng1958","volume":"39","author":"J Yamanouchi","year":"2007","unstructured":"Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VES, Gonzalez-Munoz A, Clark J, Veijola R, Cubbon R, Chen S-L, Rosa R, Cumiskey AM, Serreze DV, Gregory S, Rogers J, Lyons PA, Healy B, Smink LJ, Todd JA, Peterson LB, Wicker LS, Santamaria P (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39:329\u2013337","journal-title":"Nat Genet"},{"key":"8557_CR69","first-page":"99","volume":"6","author":"G-A Yousefipour","year":"2009","unstructured":"Yousefipour G-A, Salami Z, Farjadian S (2009) Association of HLA-DQA1* 0101\/2 and DQB1* 0502 with myasthenia gravis in southern Iranian patients. Iran J Immunol 6:99\u2013102","journal-title":"Iran J Immunol"},{"key":"8557_CR70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jim.2004.09.001","volume":"294","author":"X Yuan","year":"2004","unstructured":"Yuan X, Gubbins MJ, Berry JD (2004) A simple and rapid protocol for the sequence determination of functional kappa light chain cDNAs from aberrant-chain-positive murine hybridomas. J Immunol Methods 294:199\u2013207","journal-title":"J Immunol Methods"},{"key":"8557_CR71","doi-asserted-by":"crossref","first-page":"404053","DOI":"10.1155\/2013\/404053","volume":"2013","author":"Z Zagoriti","year":"2013","unstructured":"Zagoriti Z, Kambouris ME, Patrinos GP, Tzartos SJ, Poulas K (2013) Recent advances in genetic predisposition of myasthenia gravis. Biomed Res Int 2013:404053","journal-title":"Biomed Res Int"},{"key":"8557_CR72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/19420862.2014.985933","volume":"7","author":"K Zhang","year":"2015","unstructured":"Zhang K, Geddie ML, Kohli N, Kornaga T, Kirpotin DB, Jiao Y, Rennard R, Drummond DC, Nielsen UB, Xu L, Lugovskoy AA (2015) Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle. MAbs 7:42\u201352","journal-title":"MAbs"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-017-8557-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-017-8557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-017-8557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:15:49Z","timestamp":1693113349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-017-8557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,15]]},"references-count":72,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["8557"],"URL":"https:\/\/doi.org\/10.1007\/s00253-017-8557-1","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,15]]}}}